CatalystPit

IVVDInvivyd, Inc.

NASDAQ · Biological Products, (No Diagnostic Substances)
Last close $0.87 · 2026-09-30
ABOUT
ExchangeNASDAQ
SectorHealthcare
IndustryBiological Products, (No Diagnostic Substances)
Market cap$256.47M
RECENT INSIDER TRADES
  • 2026-08-18 · Green Julie (Chief Human Resources Officer) · SELL
  • 2026-08-18 · Andersen Jill (Chief Legal Officer, Secretary) · SELL
  • 2026-08-18 · Duke William E. (Chief Financial Officer) · SELL
  • 2026-08-18 · Allen Robert D. III (Chief Scientific Officer) · SELL
  • 2026-08-18 · Lee Timothy Edward (Chief Commercial Officer) · SELL
INSTITUTIONAL OWNERSHIP
Institutional holders136
Shares held293,127,429
Value$291.36M
Percent of shares outstanding99.45%
As of quarter end2026-06-30
RECENT NEWS
  • Invivyd grants 157,500 stock options to six new employees
  • Invivyd drops after delaying late-stage trial data for COVID therapy
  • Invivyd releases LIBERTY Phase III topline data for VYD2311
  • Invivyd reports VYD2311 shows superior safety to mRNA COVID vaccine in Phase 3
  • Invivyd pushes for broader antibody market at H.C. Wainwright conference
CatalystPit
FeaturesComing soonPricingComing soonPrivacyTermsDisclaimerAffiliate TermsContact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS